Results 11 to 20 of about 3,138,389 (246)

Proteomic and Postproteomic Characterization of Keratan Sulfate-Glycanated Isoforms of Thyroglobulin and Transferrin Uniquely Elaborated by Papillary Thyroid Carcinomas. [PDF]

open access: yes, 2003
Previous studies have suggested that surface components of papillary thyroid carcinoma (PTC) cells may be aberrantly glycanated, but the precise nature of these molecules has not been unveiled nor documented to be of clinical relevance.
Goletz, Steffen   +11 more
core   +5 more sources

External radiotherapy of thyroid cancer [PDF]

open access: yes, 2001
Differentiated thyroid cancer comprises papillary, mixed papillary-follicular and follicular adenocarcinomas. They are mostly hormone-sensitive and respond to thyroid-stimulating hormone (TSH) suppression. The standard treatment is total thyroidectomy. I-
Pollinger, B., Dühmke, Eckhart
core   +1 more source

Increasing incidence of thyroid cancer in shanghai, China, 1983-2007 [PDF]

open access: yes, 2011
Increasing incidences of thyroid cancer were observed in some countries, like USA, UK, France, etc. Jointpoint regression was used to analyze the incidence of thyroid cancer in Shanghai, China, from 1983 to 2007.
Youxin Wang, Wei Wang
core   +1 more source

Identifying key genes of classic papillary thyroid cancer in women aged more than 55 years old using bioinformatics analysis

open access: yesFrontiers in Endocrinology, 2022
BackgroundThe incidence rate of thyroid carcinoma (THCA) markedly increased in the recent few decades and has been likely over-diagnosed, especially papillary thyroid cancer (PTC) in women.
Chang-Chun Li   +8 more
doaj   +1 more source

Aberrantly methylated genes in human papillary thyroid cancer and their association with BRAF/RAS mutation.

open access: yesFrontiers in Genetics, 2013
Cancer arises through accumulation of epigenetic and genetic alteration. Aberrant promoter methylation is a common epigenetic mechanism of gene silencing in cancer cells.
Yasuko eKikuchi   +11 more
doaj   +1 more source

Metastatic papillary thyroid carcinoma in pleural effusion: a case report and review of the literature

open access: yesJournal of Medical Case Reports, 2023
Introduction Papillary thyroid carcinoma accounts for the most common type of thyroid cancer of well-differentiated type. Papillary thyroid carcinoma is featured by biologically low-grade and less aggressive tumors with a survival rate of 10 years in ...
Mohammed Ali Abutalib   +5 more
doaj   +1 more source

Incidence and mortality trends of thyroid cancer from 1980 to 2016

open access: yesSwiss Medical Weekly, 2021
AIMS OF THE STUDY: Thyroid cancer incidence rates have been increasing globally over past decades. However, no study examining those trends in the canton of Zurich, Switzerland exists.
Simon Wirth   +6 more
doaj   +1 more source

Long-term therapeutic outcomes of papillary thyroid carcinoma with concomitant hyperparathyroidism: A single center case-control study

open access: yesBiomedical Journal, 2020
Background: Papillary thyroid carcinoma occasionally presents with concomitant hyperparathyroidism; however, the clinical significance has not been well established.
Chih-Yiu Tsai   +4 more
doaj   +1 more source

Research Progress of Molecular Regulatory Mechanism of Non-coding RNAs in Papillary Thyroid Carcinoma

open access: yesZhongliu Fangzhi Yanjiu, 2021
Papillary thyroid carcinoma is one of the most common thyroid cancer subtypes. Although papillary thyroid carcinoma can be treated effectively with excision, microwave ablation, radioactive iodine and hormone replacement therapy, these ways are ...
NIU Yanqiang   +6 more
doaj   +1 more source

Deep Neck Infection: A Typical Presentation of Papillary Thyroid Cancer

open access: yesCase Reports in Otolaryngology, 2021
Deep neck infection is defined as an infectious process in the potential spaces and fascial plane of the neck which may result in a fatal complication. Prompt drainage and broad-spectrum antibiotics are the mainstays of treatment.
Apichana Mahattanapreut   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy